Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Sven T Sowa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Aapistie 7, 90220 Oulu, Finland. Hauptthemen laut MEDLINE: Tankyrases, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse S?r-?st RHF, Minerva Foundation, Jane ja Aatos Erkon S??ti?.
Abstract (Originalsprache)
Designing inhibitors is a complex task that requires a deep understanding of protein-ligand interactions and their dynamics. Ligands often interact with multiple binding subsites, with noncovalent interactions affecting binding affinity. Conformational changes and plasticity of both, the ligand and the protein influence binding energetics. We investigated the tankyrase ADP-ribosyltransferase as a promising drug target regulating many cellular pathways. Despite the existence of diverse tankyrase inhibitors, their binding energetics and contributions of flexible cryptic subpockets to binding affinity remain elusive. To examine these aspects, we deconstructed inhibitors to key fragments, dissected their energetic contribution to the affinity, and determined their binding mode by X-ray crystallography. Varying ligand efficiencies of the deconstructed, pocket-binding fragments revealed the cryptic nature of subpockets. These insights enabled us to redesign inhibitors with novel linkers, the observed key area for optimization, increasing the potency in enzymatic and cell-based assays by 7.5-fold and 6.2-fold compared to the parent ligand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Aapistie 7, 90220 Oulu, Finland.
- Medicinal Chemistry, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Campus Berlin Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany.
- In Silico Toxicology and Structural Bioinformatics, Institute of Physiology, Charité Universitätsmedizin Berlin, Virchowweg 6, 10117 Berlin, Germany.
- Oslo University Hospital, P.O. Box 4950, Nydalen, 0424 Oslo, Norway.
- Hybrid Technology Hub─Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, 0317 Oslo, Norway.
- Symeres Netherlands B.V., Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands.
ORCID-Profile: David A Schaller, Davide Cirillo, Ruben G G Leenders, Andrea Volkamer, Lari Lehtiö, Marc Nazaré
Förderung
- Helse S?r-?st RHF
- Minerva Foundation
- Jane ja Aatos Erkon S??ti?
Zitieren
APA
Sowa, S. T., Kücükdisli, M., Mostinski, Y., Schaller, D. A., Vinagreiro, C. S., Cirillo, D., Bosetti, C., Brinch, S. A., van Laar, K., Wegert, A., Leenders, R. G. G., Krauss, S., Waaler, J., Volkamer, A., Lehtiö, L., & Nazaré, M. (2025). Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02845
Vancouver
Sowa ST, Kücükdisli M, Mostinski Y, Schaller DA, Vinagreiro CS, Cirillo D, et al. Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02845
BibTeX
@article{Sowa2025,
author = {Sowa, Sven T and Kücükdisli, Murat and Mostinski, Yelena and Schaller, David A and Vinagreiro, Carolina S and Cirillo, Davide and Bosetti, Chiara and Brinch, Shoshy Alam and van Laar, Kirsten and Wegert, Anita and Leenders, Ruben G G and Krauss, Stefan and Waaler, Jo and Volkamer, Andrea and Lehtiö, Lari and Nazaré, Marc},
title = {Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02845}
}
EUVIMED